Core A: Administrative Core
核心A:行政核心
基本信息
- 批准号:10684197
- 负责人:
- 金额:$ 14.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-03 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdvocateAuthorization documentationCancer BurdenCancer CenterClinicalCollaborationsCommunitiesDevelopmentDropsEnsureFeedbackFundingGoalsGrantGynecologic OncologyInstitutionLeadershipMalignant neoplasm of ovaryMonitorPatientsPerformanceRecommendationReproduction sporesResearchResearch PersonnelResourcesRoleStructureSupervisionTimeTranslational ResearchWorkauthoritycareerexperienceflexibilityimprovedoncology programprogramsresistance mechanismsuccess
项目摘要
PROJECT SUMMARY
Administrative Core
The overarching goals of the Administrative Core of this Dana-Farber/Harvard Cancer Center (DF/HCC)
Ovarian Cancer SPORE application are to provide leadership and administrative oversight of the overall grant,
integration of the SPORE components as well as integration of the overall Ovarian Cancer SPORE within the
Dana-Farber/Harvard Cancer Center (DF/HCC), and promote and engage activities that allow the success of
the Ovarian Cancer SPORE Projects, Cores, the Developmental Research Program (DRP) and the Career
Enhancement Program (CEP). Drs. Matulonis, D’Andrea, and Spriggs will work within the multi-PI/PD
framework. The Leaders of this Ovarian Cancer SPORE grant, Drs. Matulonis, D’Andrea, and Spriggs, will
work directly with the DF/HCC SPORE Committee, the External Advisory Board (EAB), the Internal Advisory
Board (IAB), and the Ovarian Cancer SPORE Advocate Board to obtain recommendations and feedback and
implement them into the DF/HCC Ovarian Cancer SPORE components and the overall grant. The Overall
Directors of this SPORE grant, Drs. Matulonis, D’Andrea, and Spriggs, will equally closely monitor projects
throughout the entirety of the granting period and, in return, give constant and real time input; they will also
have the authority to alter funding based upon project performance, and they will do this collaboratively. The
structure of this SPORE grant will allow close supervision of all Projects and Cores and flexibility to allow
project revision based on oversight feedback and whether underperforming projects should be dropped
altogether or replaced. The SPORE PIs/PDs will ensure and facilitate interaction among the projects as well as
access to SPORE resources such as Cores. The DRP and CEP will function as a critical pipeline of
scientifically and clinically noteworthy projects and investigators that could be incorporated into the SPORE
based on the advice of the advisory boards (EAB and IAB) and the DRP and CEP leadership; Drs. Matulonis
and Spriggs will have direct oversight of the DRP and CEP.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN D. D'ANDREA其他文献
ALAN D. D'ANDREA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN D. D'ANDREA', 18)}}的其他基金
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
达纳法伯/哈佛大学癌症中心卵巢癌孢子补助金
- 批准号:
10024413 - 财政年份:2020
- 资助金额:
$ 14.77万 - 项目类别:
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
达纳法伯/哈佛大学癌症中心卵巢癌孢子补助金
- 批准号:
10228046 - 财政年份:2020
- 资助金额:
$ 14.77万 - 项目类别:
Novel Strategies to Extend DNA Repair Therapies for Triple Negative Breast Cance
延长三阴性乳腺癌 DNA 修复疗法的新策略
- 批准号:
8607755 - 财政年份:2013
- 资助金额:
$ 14.77万 - 项目类别:
相似海外基金
OncoPath: Intelligent Clinical Pathway Decision Support Tool for Pre-Authorization Documentation in Non-Small Cell Lung Cancer Treatment
OncoPath:用于非小细胞肺癌治疗预授权文档的智能临床路径决策支持工具
- 批准号:
10325551 - 财政年份:2021
- 资助金额:
$ 14.77万 - 项目类别:














{{item.name}}会员




